Grindr Inc. filed a Form 8-K with the SEC on November 2, 2026, disclosing the completion of its acquisition of PurposeMed Inc. for an upfront purchase price of approximately $250.0 million, with potential additional earnout consideration of up to $70.0 million.

Key Highlights

  • Acquisition closed: Grindr completed the purchase of all issued and outstanding shares of PurposeMed Inc. on November 2, 2026.
  • Upfront purchase price: Approximately $250.0 million, subject to customary purchase price adjustments, consisting of $190.0 million in cash and $60.0 million in Grindr common stock.
  • Shares issued: An aggregate of 3,851,684 shares of Grindr common stock, par value $0.0001 per share, were issued as part of the consideration.
  • Earnout potential: Sellers are eligible to receive up to $70.0 million in additional cash, contingent on PurposeMed achieving certain financial performance targets for the fiscal year ending December 31, 2027.
  • Purchase Agreement date: The Securities Purchase Agreement was originally dated September 30, 2026, among Grindr, its wholly owned Canadian subsidiary 18273618 Canada Inc., PurposeMed, the sellers, and Dr. Husein Moloo as sellers' representative.
  • Signed by: The filing was signed by John North, Chief Financial Officer of Grindr Inc.

Grindr Completes PurposeMed Purchase with Mixed Cash and Stock Deal

According to the Form 8-K filed with the SEC, Grindr Inc. (NYSE:GRND) completed its acquisition of PurposeMed Inc. on November 2, 2026, the same date the filing was made. The transaction was carried out pursuant to a Securities Purchase Agreement signed on September 30, 2026. The counterparties to that agreement included Grindr, its wholly owned Canadian subsidiary 18273618 Canada Inc., PurposeMed, the shareholders of PurposeMed party to the agreement, and Dr. Husein Moloo, who served solely in his capacity as the sellers' representative.

The filing disclosed that Grindr acquired all of the issued and outstanding shares of PurposeMed for an upfront purchase price of approximately $250.0 million, subject to customary purchase price adjustments. That consideration was structured as $190.0 million in cash and $60.0 million in shares of Grindr common stock, representing an aggregate of 3,851,684 shares at a par value of $0.0001 per share. The filing did not specify a per-share price used to calculate the stock component.

In addition to the upfront consideration, the filing stated that the sellers are also eligible to receive earnout consideration of up to $70.0 million in cash, contingent on the PurposeMed business achieving certain financial performance targets for the fiscal year ending December 31, 2027. The filing noted that a press release dated November 2, 2026, announcing the completion of the acquisition was attached as Exhibit 99.1 and incorporated by reference under Item 7.01, Regulation FD Disclosure. The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, according to the filing.

What Was Disclosed

Grindr Inc. reported the closing of its acquisition of PurposeMed Inc. for approximately $250.0 million upfront, split between $190.0 million in cash and 3,851,684 shares of common stock, plus up to $70.0 million in contingent earnout payments tied to 2027 performance targets.